Joaquín Belón

495 total citations
4 papers, 348 citations indexed

About

Joaquín Belón is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joaquín Belón has authored 4 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Joaquín Belón's work include Gastric Cancer Management and Outcomes (2 papers), Cancer Treatment and Pharmacology (2 papers) and HER2/EGFR in Cancer Research (1 paper). Joaquín Belón is often cited by papers focused on Gastric Cancer Management and Outcomes (2 papers), Cancer Treatment and Pharmacology (2 papers) and HER2/EGFR in Cancer Research (1 paper). Joaquín Belón collaborates with scholars based in Spain and United States. Joaquín Belón's co-authors include Antonio Antón, Javier Martínez‐Trufero, Francisco S. N. Lobo, Andrés Cervantes, Juan Luis Gomez Marti, Vicente Valentí, Luis Paz‐Ares, Cinta Pallarés, H. Cortés-Funes and Antonio López–Pousa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Tumori Journal.

In The Last Decade

Joaquín Belón

4 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joaquín Belón Spain	4	280	215	164	104	36	4	348
F. Rosen United States	6	314 1.1×	219 1.0×	152 0.9×	118 1.1×	58 1.6×	10	399
Paul A. Bilodeau United States	6	227 0.8×	139 0.6×	118 0.7×	111 1.1×	29 0.8×	6	284
Ka–Jia Cao China	9	246 0.9×	142 0.7×	172 1.0×	103 1.0×	24 0.7×	14	318
R. Gahbauer United States	4	302 1.1×	223 1.0×	153 0.9×	96 0.9×	30 0.8×	8	343
T. Nwizu United States	11	276 1.0×	167 0.8×	109 0.7×	140 1.3×	41 1.1×	23	340
Ch. Popella Germany	3	454 1.6×	327 1.5×	181 1.1×	210 2.0×	33 0.9×	4	504
Asaf Senft Netherlands	8	237 0.8×	112 0.5×	121 0.7×	92 0.9×	28 0.8×	10	306
Chun‐Ta Liao Taiwan	6	250 0.9×	190 0.9×	129 0.8×	64 0.6×	31 0.9×	8	311
G Cavaniglia Italy	5	445 1.6×	358 1.7×	225 1.4×	166 1.6×	37 1.0×	6	498
Dtt Chua China	7	229 0.8×	181 0.8×	151 0.9×	88 0.8×	76 2.1×	10	352

Countries citing papers authored by Joaquín Belón

Since Specialization

Citations

This map shows the geographic impact of Joaquín Belón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joaquín Belón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joaquín Belón more than expected).

Fields of papers citing papers by Joaquín Belón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joaquín Belón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joaquín Belón. The network helps show where Joaquín Belón may publish in the future.

Co-authorship network of co-authors of Joaquín Belón

This figure shows the co-authorship network connecting the top 25 collaborators of Joaquín Belón. A scholar is included among the top collaborators of Joaquín Belón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joaquín Belón. Joaquín Belón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Hitt, Ricardo, Antonio López–Pousa, Javier Martínez‐Trufero, et al.. (2005). Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 23(34). 8636–8645. 319 indexed citations

2.

Morales, Serafín, Manuel Ramos, Miguel Méndez, et al.. (2003). Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study. Cancer Chemotherapy and Pharmacology. 53(1). 75–81. 19 indexed citations

3.

Barón, Manuel González, Enrique Espinosa, Jaime Feliú, et al.. (1997). The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer. 5 indexed citations

4.

Aranda, Enrique, et al.. (1994). Phase II Study with Iododoxorubicin in Measurable Advanced Colorectal Adenocarcinoma. Effective Rescue Using Weekly High-Dose 5-Fluorouracil (WFU). Tumori Journal. 80(2). 124–127. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact